Menu

Tag: United States Food & Drug Administration

 

Shilpa Medicare tanks over 4% on USFDA observations

Shilpa Medicare shares fell by over 4.7% today after it received observations from United States Food & Drug Administration (USFDA) in relation to SEZ formulation facilities situated at Jadcherla, Telangana. Out of the 10 observations, 7 are related to improvement in procedures and practices and 3 observations are related to setting of analytical specifications, test […]

0 Comments
Read Full